Guarini Kathryninsider trades
In SEC Form 4 filings, Guarini Kathryn is listed as Director of Regeneron Pharmaceuticals, Inc. (REGN). In the last 90 days, Guarini Kathryn sold $340K of Regeneron Pharmaceuticals, Inc. (REGN) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | Director | 3 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | Sep 2 | Sep 3 | M | 400 | $719.37 | $287,748 | 1,003 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Sep 2 | Sep 3 | S | 400 | $850.00 | Sale −$340,000 | 603 | Yes | Form 4 |
| REGNRegeneron Pharmaceuticals, Inc. | Sep 2 | Sep 3 | M · derivative | 400 | $719.37 | $287,748 | 1,158 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.